@ontarget-podcast.bsky.socialHamed Amini, CEO and co-founder of #Hepta Bio, tells us how his company's #liquidbiopsy can diagnose liver fibrosis due to MASH, identifying patients who are treatment candidates.
๐ง Listen now โ www.ontargetpodcast.com
#OnTarget #PrecisionMedicine #MASH #Epigenetics #LiverDisease #Diagnostics #AI
@mdpm2026.bsky.socialExplore the Scientific Sessions at MDPM 2027!
๐
June 17โ18, 2027
๐ Zurich, Switzerland
Scientific Sessions: advancedmoleculardx.com/scientific-s...
#MDPM2027 #MolecularDiagnostics #PrecisionMedicine #Genomics #LiquidBiopsy #Biomarkers #NGS #AIinHealthcare #PersonalizedMedicine #ClinicalTrials
@darwishmd.bsky.socialBlood tests for tumor DNA (ctDNA) can spot leftover cancer months before scans do, and help doctors pick targeted drugs. New JAMA review: promising, but costs and best-use timing are still being worked out.
@bloodpac.bsky.social๐ Save the date! Join BLOODPAC's New Frontiers Seminar: Molecular Residual Disease in Hematologic Cancers: Progress, Challenges, and Future Directions
๐ Dec. 9, 2026
โฐ 1โ3 PM ET
๐ป Virtual
@islb.infoThe full #ISLB2026 Scientific Program is available!
Explore 3 days of cutting-edge liquid biopsy science, expert speakers & clinical insights in Madrid, 7โ9 Nov 2026.
๐ฉ๐ถ๐ฒ๐ ๐๐ต๐ฒ ๐ฝ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ โ islb-congress.info
@knstnr.bsky.social๐งฌ New paper! Within #InstandNGS4P we developed MRD prototypes detecting ctDNA in blood plasma to support diagnosis of pancreatic & ovarian cancer โ UMI-based error correction + ultra-deep sequencing.
๐ Open Research Europe: open-research-europe.ec.europa.eu/articles/6-87
@particle-metrix.bsky.socialWeโre heading to @helloeacr.bsky.social Liquid Biopsies in Lyon!
Meet us at Booth #15 to discover ZetaViewยฎ for multiparametric nanoparticle & EV characterization.
๐ค Sept 24 | 08:45โ09:00
Bertrand Damart: โZetaViewยฎ Evolution: A new edge for nanoparticle characterization.โ
#EACR #EVs #LiquidBiopsy
@mdpm2026.bsky.socialAdvances in Molecular Diagnostics and Precision Medicine 2027
๐
June 17โ18, 2027
๐ Zurich, Switzerland
Registration: advancedmoleculardx.com/registrations/
#MDPM2027 #LiquidBiopsy #MolecularDiagnostics #PrecisionMedicine #ctDNA #CancerDiagnostics #Genomics #PersonalizedMedicine #SciinovGroup
@drjkyl.bsky.socialBiomarker-guided selection of intravesical therapy in high-risk nonโmuscle invasive bladder cancer: A contemporary review
Therapeutic Advances in Urology
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#artificialintelligence #liquidbiopsy #cancerdetection #oncology #openaccess
@islb.infoStudents & early-career researchers: take the next step at #ISLB2026. ๐ฌ Explore the latest in #LiquidBiopsy, connect with global experts and join the community shaping the field.
Student rates availableโsave more with Early Bird registration by 2 Oct 2026.
๐ฅ๐ฒ๐ด๐ถ๐๐๐ฒ๐ฟ ๐ก๐ผ๐ โ islb-congress.info
@mdpm2026.bsky.socialJoin us at MDPM 2027 to explore the future of precision diagnostics.
๐
June 17โ18, 2027
๐ Zurich, Switzerland
Registration:
advancedmoleculardx.com/registrations/
#MDPM2027 #LiquidBiopsy #MolecularDiagnostics #PrecisionMedicine #Genomics #Biomarkers #NGS #AI #Healthcare #SciinovGroup
@myesmo.bsky.social#MAP2026: Novel tests based on epitranscriptomics and detection of cell-free CTCF-DNA fragments could help #LiquidBiopsy fulfil its promise of #EarlyDetection of cancer, with early results showing high sensitivity and specificity. #ESMODailyReporter: https://ow.ly/CrSC50ZLWgI
@ontarget-podcast.bsky.social#AjitSingh, CEO of Harbinger Health, explains how his company's diagnostic determines whether a patient with nonspecific clinical signs has cancer.
๐ง Listen now โ www.ontargetpodcast.com
#OnTarget #PrecisionMedicine #LiquidBiopsy #Oncology #AI #Diagnostics #HarbingerHealth #RESOLVE #EarlyDetection
@pmac-group.bsky.socialSERENA-6 provides prospective evidence that serial #ctDNA monitoring can detect emerging ESR1-mediated resistance and guide an endocrine switch before radiographic progression moving #LiquidBiopsy from detection to intervention.
@islb.infoWhat awaits at ISLB 2026 in Madrid?
Explore expert-led workshops, oral abstract presentations, poster sessions and a guided poster tourโplus the latest research, technologies and clinical applications in liquid biopsy.
๐๐ฒ๐ฎ๐ฟ๐ป ๐บ๐ผ๐ฟ๐ฒ โ islb-congress.info